Vectura Group plc, headquartered in Great Britain, is a leading player in the pharmaceutical industry, specialising in the development of inhalation products and drug delivery solutions. Founded in 1997, Vectura has achieved significant milestones, including partnerships with major pharmaceutical companies to enhance respiratory therapies. The company focuses on innovative formulations and device technologies, particularly for asthma and chronic obstructive pulmonary disease (COPD). Vectura's unique approach combines expertise in inhalation science with advanced manufacturing capabilities, positioning it as a trusted partner in the respiratory market. With a strong presence in Europe and North America, Vectura has established itself as a key contributor to improving patient outcomes through its core products and services. Its commitment to research and development continues to drive its success and market leadership in the inhalation therapeutics sector.
How does Vectura's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Vectura's score of 27 is lower than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Vectura reported total carbon emissions of approximately 14,578,000 kg CO2e, with about 13,983,000 kg CO2e classified under Scope 3 emissions, and approximately 595,000 kg CO2e from Scope 1 and 2 combined. This marks a slight increase from 2022, when total emissions were about 14,385,000 kg CO2e, with Scope 3 emissions at approximately 13,981,000 kg CO2e and Scope 1 and 2 emissions at around 404,000 kg CO2e. Vectura's emissions data is cascaded from its parent company, Vectura Group plc, reflecting a corporate family relationship. The company has not set specific reduction targets or initiatives as part of the Science Based Targets initiative (SBTi) or other climate pledges. The absence of defined reduction strategies highlights the need for Vectura to enhance its climate commitments in line with industry standards, particularly given the significant proportion of emissions attributed to Scope 3, which often encompasses indirect emissions from the supply chain and product use.
Access structured emissions data, company-specific emission factors, and source documents
| 2014 | 2017 | 2018 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Scope 1 | 142,000 | 0,000,000 | 0,000,000 | - | - |
| Scope 2 | 1,272,000 | 0,000,000 | 0,000,000 | - | - |
| Scope 3 | - | - | - | 00,000,000 | 00,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Vectura is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
